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Paromomycin, an aminoglycoside antibiotic having low mammalian cell toxicity, is one of the drugs currently
used in the chemotherapy of cutaneous and visceral leishmaniasis. In order to understand the mode of action
of this antibiotic at the molecular level, we have investigated the effects of paromomycin on protein synthesis
in Leishmania and its mammalian hosts. We were able to demonstrate that in vivo protein synthesis in the
promastigote stage of the parasite and its proliferation rate are markedly inhibited by paromomycin while
being only slightly affected by other aminoglycoside antibiotics, such as streptomycin and neomycin B. Fur-
thermore, both in vitro polypeptide synthesis induced by poly(U) as mRNA and accuracy of translation are
significantly decreased by paromomycin in cell-free systems containing ribosomal particles of Leishmania
promastigotes. Conversely, when ribosomes from mammalian cells are used instead of the protozoan particles,
polyphenylalanine synthesis is only barely reduced by the antibiotic and the translation misreading remains
almost unaltered. Surface plasmon resonance analysis of the interaction between paromomycin and protozoan
or mammalian cell ribosomal RNAs shows a strong binding of antibiotic to the parasite ribosomal decoding
site and practically no interaction with the mammalian cell counterpart. Our results indicating differential
effects of paromomycin on the translation processes of the Leishmania parasite and its mammalian hosts can
explain the therapeutic efficiency of this antibiotic as an antileishmaniasis agent.
Leishmaniasis, a parasitic disease caused by protozoa of the
genus Leishmania, affects millions of people in different re-
gions of the world, mainly in tropical and subtropical areas.
The disease may reach an appreciable mortality rate and may
adopt several forms in human patients, ranging from cutane-
ous and mucocutaneous lesions to a severe visceral form af-
fecting various organs (7, 10, 20).
Leishmania has a digenetic life cycle involving an insect
vector and a mammalian host. The parasite undergoes major
morphological and physiological transformations during the
different stages of its life cycle. Promastigotes are elongated
and flagellated forms proliferating inside the sandfly, whereas
amastigotes are rounded, flagellumless forms that multiply in-
side the mammalian host cells (20).
Over the years, a good number of drugs have been used in
the clinical treatment of leishmaniasis. In general, these che-
motherapies have usually been selected on empirical bases and
not through an extensive knowledge of Leishmania metabolic
selective features (20, 26). Up to the present time, several
compounds have shown rather satisfactory results; however,
most of these drugs have some limitations, such as high levels
of toxicity in humans or the development of resistance mech-
anisms in parasites (27). Pentavalent antimonial compounds,
pentamidine and amphotericin B, are very well known among
the chemicals currently used in leishmaniasis therapy (20).
Although their corresponding modes of action have not been
completely elucidated yet, some possible mechanisms have
been suggested. Pentavalent antimony undergoes an in vivo
reduction into a trivalent form which is toxic to amastigotes
and promastigotes. Pentamidine, which is able to substitute
polyamines at their sites of binding to nucleic acids, might
produce the inhibition of DNA replication and transcription
(3), whereas amphotericin B is selectively toxic to parasites,
probably due to its affinity to ergosterol, causing protozoan
membrane damage (5).
Other chemicals have more recently been introduced in the
therapy of leishmaniasis. Allopurinol and various purine ana-
logs are effective because they inhibit the enzyme adenylosuc-
cinate synthetase, which mediates the conversion of inosinic
acid into AMP (19). Several natural products, such as quinones
and terpene derivatives, have also shown antileishmanial ac-
tivity (29, 30, 31, 35).
Recent studies on Leishmania biochemical pathways (26)
have intended to detect metabolic processes occurring exclu-
sively in the parasite and not in mammalian cells. In this way,
it would be possible to find new strategies involving specific
targets, such as trypanothione or glycosylphosphatidylinositol
biosyntheses, which might be appropriate for the design of
selective chemotherapies (38).
Several aminoglycoside antibiotics mainly used in bacterial
infections have been tried as antiparasitic agents. Among
them, paromomycin (aminosidine) has shown antileishmanial
activity when used alone or in combination with other drugs (7,
10, 17, 18, 20). Topical treatments with paromomycin-contain-
ing ointments or intramuscular injections of the same antibi-
otic have been successfully used for a long time against cuta-
neous or visceral leishmaniasis, respectively (7, 23, 32, 34).
However, very little is known about the differential effects of
the drug on parasites and mammalian host cells. These selec-
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tive activities might be related to the antibiotic actions on
bacterial ribosomes causing the inhibition of their dissociation
into subunits with the concomitant decrease of protein synthe-
sis (17) and/or the induction of mistranslation errors by the
specific interaction of paromomycin with the small rRNA de-
coding site (11, 36).
A multistep model has been proposed to explain the bacte-
ricidal effect of aminoglycosides, which involves antibiotic up-
take, mistranslation by chain-elongating ribosomes, membrane
damage, and subsequent ribosomal blockade preventing fur-
ther protein synthesis (9). This model might also be relevant to
the paromomycin mode of action on Leishmania, because the
parasite ribosomes are good targets for the antibiotic (17).
In the present article, we show that paromomycin causes a
strong inhibition of polyphenylalanine synthesis directed by
poly(U) in a cell-free system prepared from Leishmania mexi-
cana promastigotes and that this effect is considerably smaller
when rat liver ribosomes replace the parasite particles. More-
over, the misreading frequency of leucine incorporation with
poly(U) as a messenger is 10-fold higher when Leishmania
mexicana ribosomes are used instead of those from mamma-
lian systems. These results could explain the selective action of
paromomycin on in vivo protein synthesis and protozoan pro-
liferation. Surface plasmon resonance (SPR) measurements of
the specific antibiotic binding to RNA oligonucleotides corre-
sponding to a segment of the small ribosomal subunit decoding
sites indicate that paromomycin interaction occurs only with
the oligonucleotide from Leishmania ribosomes and not with
that from mammalian particles. These results strongly suggest
a selective antiparasitic effect of paromomycin.
MATERIALS AND METHODS
Chemicals. The antibiotics paromomycin, neomycin, streptomycin, and ampi-
cillin and reagents ATP, GTP, L-amino acids, bases, creatine phosphate, creatine
phosphokinase, poly(U) as K salt, wheat germ tRNA, hemin, and HEPES buffer
were obtained from Sigma (St. Louis, MO). Minimal essential medium (SMEM)
and vitamins were from Gibco/BRL (Gaithersburg, MD). Fetal calf serum was
purchased from Natocor (Carlos Paz, Co´rdoba, Argentina), and radioactive
amino acids L-[U-14C]leucine (318 mCi/mmol), L-[U-14C]phenylalanine (496
mCi/mmol), and L-[35S]methionine (1,175 Ci/mmol) were obtained from Perkin-
Elmer (Boston, MA).
Parasite cultures and cell extract preparation and fractionation. Crithidia
fasciculata (ATCC 11745) and Leishmania mexicana (MHOM/BZ/82/BEL21)
were cultivated at 26 to 28°C in the semidefined medium SDM-79 (6) supple-
mented with hemin (20 mg/liter), 10% heat-inactivated fetal calf serum, and
antibiotics (100 g/ml streptomycin and 100 U/ml penicillin). Parasite growth
was followed by cell counting, and all cultures reaching the stationary phase were
diluted with fresh medium to (5 to 10) 106 cells/ml. Parasites at the exponential
phase of growth were collected by centrifugation at 1,000  g for 10 min. Cells
were resuspended in a solution containing 20 mM HEPES-KOH buffer, pH 7.5,
2 mM Mg acetate, 80 mM KCl, and 1 mM dithiothreitol (DTT) at a concentra-
tion of 2  109 cells/ml and then broken by freezing at 80°C and thawing for
4 consecutive times. Cell extracts were centrifuged at 4°C (20 min at 30,000  g),
and the supernatant fluids (S30) were dialyzed for 3 h against 10 mM HEPES
buffer, pH 7.5, 1 mM Mg acetate, 20 mM KCl, and 1 mM DTT. S30 fractions were
directly used to measure polypeptide synthesis induced by poly(U) as mRNA or
for further isolation of S150 supernatant fractions (after a new centrifugation at
150,000  g for 3 h) and subsequent purification of parasite cytoplasmic ribo-
somal particles by sucrose gradient centrifugation similar to that described for rat
liver ribosomes.
Rat liver extracts and purification of the ribosomal fraction. About 20 g of rat
liver tissue was cut into small pieces and disrupted by 10 strokes in a tight-fitting
Teflon-glass homogenizer using 80 ml of 0.25 M sucrose containing 50 mM
Tris-HCl buffer, pH 7.5, 5 mM Mg acetate, 250 mM KCl, 2 mM DTT, and 0.5 mg
heparin/ml as a nuclease inhibitor. After treatment at 4°C for 15 min with
-amylase (10 U/ml) in the presence of 0.1 mM CaCl2 for glycogen degradation,
the liver extract was centrifuged at 12,000  g for 15 min. The postmitochondrial
supernatant fluid was treated with 1% Triton X-100 and 0.5% Na deoxycholate
(final concentrations), and the mixture was placed on top of a two-step sucrose
gradient made of 2 ml 1.5 M and 4 ml 2 M sucrose, both in a buffer solution
containing 50 mM Tris-HCl (pH 7.5), 5 mM Mg acetate, 50 mM KCl, 2 mM
DTT, and 0.1 mg of heparin/ml. Centrifugation was performed at 150,000 g for
16 h in a Beckman Ti60 rotor. The ribosomal pellet was carefully rinsed with a
solution containing 10 mM Tris-HCl (pH 7.5), 10 mM KCl, and 1.5 mM Mg
acetate and then resuspended in the same solution to a concentration of 500 A260
U/ml and stored in a freezer at80°C. The rat liver S150 supernatant fraction was
obtained from dialyzed S30 extracts as described for parasite fractions.
In vivo protein synthesis in Leishmania mexicana promastigotes. The rate of
total protein synthesis was followed in aliquots of an exponentially growing
parasite culture in the absence and presence of aminoglycoside antibiotics. The
drug to be tested was added, and after a 15-min period to allow the antibiotic
uptake, radioactive methionine was added (10 Ci/ml) and the incubation was
continued at 37°C for 4 h. Samples were taken at the indicated times, and after
treatment for 15 min at 37°C with an equal volume of 1 M NaOH containing 1
mM unlabeled methionine and albumin (20 g/ml) as a carrier, proteins were
precipitated with trichloroacetic acid (10% final concentration). After filtration
through Whatman GF/C filters, the samples were washed with 10% trichloro-
acetic acid (TCA)–95% ethanol and then dried and counted in a scintillation
spectrometer.
In vitro polypeptide synthesis induced by poly(U) in parasite and rat liver
systems. The reaction was carried out in a total volume of 0.1 ml containing 30
mM HEPES-KOH (pH 7.5), 50 mM K acetate, 5 to 10 mM Mg acetate, 0.1 mM
EDTA, 1 mM ATP, 0.2 mM GTP, 8 mM creatine phosphate, 20 g creatine
phosphokinase, 2 mM DTT, 40 g of stripped wheat germ tRNA, 50 g of
poly(U), radioactive phenylalanine (0.1 Ci, 20 M [final concentration]), and
S30 supernatant fraction (40 to 60 g of protein), or 0.3 to 0.5 A260 units of
purified ribosomes plus S150 supernatant fraction (20 to 40 g of protein). The
reaction was carried out for 40 min at 37°C and subsequently treated as described
above. The addition of paromomycin at different concentrations allowed us to
study the effect of this antibiotic on polypeptide synthesis.
Mistranslation frequency induced by antibiotics in parasite and mammalian
systems. The reaction mixture was similar to that described for poly(U)-depen-
dent polypeptide synthesis, containing an S150 fraction from Leishmania mexi-
cana and purified ribosomes obtained from parasites or rat liver. Different
aliquots from the same preparations were used for the assays of radioactive
phenylalanine or leucine incorporation in the presence of unlabeled leucine or
phenylalanine, respectively. Where indicated, 20 M paromomycin was added to
the reaction mixtures. Mistranslation was measured as the percentage of leucine
incorporation compared to that of phenylalanine.
Oligoribonucleotides corresponding to a segment of rRNA decoding region.
Polyribonucleotides with biotin followed by the TEG spacer at the 5 end were
prepared by Integrated DNA Technologies, Inc. (Coralville,IA). The polymers L
and M have sequences corresponding to helix 44 within the decoding region of
the cytoplasmic small ribosomal RNAs from Leishmania spp. and Homo sapiens
(mammalian systems), respectively (14). The polymer N has a similar size but an
unrelated sequence in the region relevant for antibiotic binding. The RNA
oligonucleotide sequences are the following: L, 5-/5BioTEG/rCrArCrCrGrCrC
rCrGrUrCrGrUrUrGrUrUrUrCrCrArArGrUrCrGrGrCrGrArGrGrArArGrC
rArArArArGrUrCrGrUrArArCrArArGrGrUrA-3; M, 5-/5BioTEG/rCrArCr
CrGrCrCrCrGrUrCrGrCrUrArCrUrArCrCrArArGr. UrCrGrGrCrGrArGrGr
ArArGrUrArArArArGrUrCrGrUrArArCrArArGrGrUrA-3; N, 5-/5BioTEG/
rCrArCrCrGrCrCrCrGrUrCrGrCrUrArCrUrArCrCrArArGrUrCrGrArC
rUrUrGrGrUrArGrUrArGrCrGrArCrGrGrGrCrGrGrUrG-3.
Immobilization of biotinylated RNAs on the sensor chips. Streptavidin sensor
chips were prepared from carboxymethyl dextran sensor chips (CM5) by amino
coupling immobilization according to the manufacturer’s directions. Briefly,
streptavidin solution (1 mg/ml) was dialyzed against buffer acetate (10 mM; pH
4.5) and then injected over the four flow cells of the sensor chips prior to
activation with N-hydroxysuccinimide (NHS) and N-(3-dimethylaminopropyl)-
N-ethylcarbodiimide hydrochloride (EDC). The free active sites after strepta-
vidin binding were blocked with ethanolamine. An average of 5,000 resonance
units (RU) of RNA oligomer was immobilized in each flow cell. Using a manual
injection, three pulses of biotinylated RNA from Leishmania, a negative control
RNA, or a human rRNA was injected over the flow cells. All the ligands were
diluted at a final concentration of 5 pmol in 80 l of buffer (10 mM HEPES, 0.1
mM EDTA, 100 mM NaCl, pH 6.8) as described by Hendrix et al. (13).
Surface plasmon resonance studies. The interactions of immobilized RNA
with antibiotics were measured by SPR using a Biacore T100 instrument (GE
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Healthcare, Uppsala, Sweden) that allows determination of real-time interac-
tions between two molecules (16).
Micromolar concentrations of the aminoglycoside antibiotics paromomycin
and neomycin were prepared by 2-fold dilution with HEPES-buffered saline
(HBS) containing 150 mM NaCl and 0.005% surfactant P-20 (BIAcore) (pH 7.2).
All binding experiments were performed at 25°C. Dissociation was carried out in
HBS. Pulses of 300 mM Na2SO4 were used to regenerate the surface. SPR data
were analyzed using Biacore T100 evaluation software. All the experiments were
repeated at least three times, and residuals were less than 5%. Dissociation
constants (KD) were determined under equilibrium binding conditions fitting a
1:1 binding nonlinear model after correction for nonspecific interaction, in which
the aminoglycoside was passed over the unspecific RNA (N) used as a negative
control.
RESULTS
Effects of paromomycin on Leishmania growth. In order to
investigate the selective effects of paromomycin on parasites of
Leishmania spp., we followed the proliferation of Leishmania
mexicana in SDM-79 medium. Cultures were performed in the
absence and presence of different concentrations of the drug.
We also used control cultures with the addition of other ami-
noglycoside antibiotics, such as streptomycin or neomycin B.
Paromomycin inhibited Leishmania growth in a dose-depen-
dent manner, as shown in Fig. 1, while streptomycin and neo-
mycin B elicited a very small effect or no effect at all on
parasite proliferation. The paromomycin concentration caus-
ing 50% of Leishmania growth inhibition (IC50) was about 200
M, a rather high value in comparison with previously re-
ported data (15). This discrepancy might be due to the fact that
Leishmania promastigotes with lower paromomycin uptake
and sensitivity than amastigote forms were used in our studies
(15).
Effects of paromomycin on Leishmania protein synthesis in
vivo. Total protein synthesis was measured in intact parasites
labeled with radioactive methionine as described in Materials
and Methods. Leishmania mexicana promastigotes were culti-
vated in the absence and presence of various paromomycin
levels. In addition, different aliquots of the same parasite cul-
ture were incubated with streptomycin or neomycin B. The
results shown in Fig. 2 agree with those observed for parasite
proliferation. In vivo protein synthesis was markedly decreased
by paromomycin but almost unaffected or slightly inhibited by
streptomycin or neomycin B. The presence of streptomycin in
the growth medium did not modify the inhibitory effects of
paromomycin on Leishmania proliferation and protein syn-
thesis.
It was ruled out that paromomycin could alter methionine
uptake by Leishmania promastigotes because this amino acid
transport gave very similar values in the absence and presence
of the antibiotic (3.5  0.6 and 3.9  0.8 pmol/min/107 para-
sites, respectively). Therefore, the results shown in Fig. 2 are
due to antibiotic inhibition of protein synthesis and not to
effects on amino acid transport.
Paromomycin inhibition of polyphenylalanine synthesis in
cell extracts or purified fractions from protozoa and rat liver.
Cell extracts from different parasites and rat liver are able to
efficiently translate synthetic polynucleotides. We studied the
in vitro polypeptide synthesis directed by poly(U) as a messen-
ger in systems prepared from Leishmania mexicana, Crithidia
fasciculata, and rat liver. In the absence of mRNA, the incor-
poration of amino acids into polypeptides was negligible in all
these systems. Upon the addition of the synthetic polynucle-
otide poly(U), the incorporation of phenylalanine (codons
UUU and UUC) was stimulated between 50 and 100 times (1).
Preliminary experiments have indicated that under our exper-
imental conditions, the optimal Mg2 concentration required
for maximal phenylalanine incorporation into polypeptides
was 7 mM for all the systems investigated (results not shown).
The effects of paromomycin concentrations on polypeptide
synthesis directed by poly(U) in cell-free systems (S30 frac-
tions) from parasites and rat liver are shown in Fig. 3A and B,
respectively. The antibiotic strongly inhibited polyphenylala-
nine formation in mixtures derived from Crithidia fasciculata
and Leishmania mexicana, with a 50% inhibition at 16 and 34
M, respectively (Fig. 3A). These lower IC50s are due to the
fact that they correspond to an in vitro experiment where there
is direct access of the drug to ribosomal particles; IC50s corre-
sponding to in vivo assays (Fig. 1 and 2) are markedly higher.
Unexpectedly, at low concentrations, the aminoglycoside pres-
ence enhances polypeptide synthesis in a reaction mixture con-
taining an S30 supernatant fraction from rat liver, as can be
seen in Fig. 3B. Since this remarkably different effect on rat
liver systems might be due to specific features of the ribosomal
particles or to properties of the enzymatic activities present in
FIG. 1. Inhibition of Leishmania mexicana growth by aminoglyco-
side antibiotics. Parasites were cultivated in SDM-79 medium in the
absence of antibiotics (E) or with the addition of 0.4 mM streptomycin
(F), 0.4 mM neomycin B (Œ), or 0.2 mM () or 0.4 mM (f) paro-
momycin. Parasite proliferation was followed for 72 h.
FIG. 2. Effect of aminoglycoside antibiotics on Leishmania mexi-
cana protein synthesis in vivo. Parasites at the exponential phase of
growth in the absence or presence of antibiotics were labeled with
radioactive methionine (Met) and treated as indicated in Materials
and Methods. Cultures without antibiotics (E) or in the presence of 0.4
mM streptomycin (F), 0.4 mM neomycin B (Œ), or 0.2 mM () or 0.4
mM (f) paromomycin were used.
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the supernatant fraction, we compared paromomycin effects on
polypeptide synthesis in reaction mixtures differing only in the
origin of ribosomes. The results shown in Fig. 3C indicate that
while paromomycin elicited strong inhibition of polyphenylala-
nine synthesis performed by parasite ribosomes, as shown be-
fore, the antibiotic provoked only a slight decrease in the same
reaction when mammalian particles were used. We obtained
similar results using a different protocol to prepare parasite
and liver fractions. This method did not include detergents to
release ribosomes from membranes, so microsomes were dis-
carded, and the resulting preparations correspond to purified
free ribosomes.
Effects of paromomycin on mistranslation in cell-free sys-
tems containing protozoan or mammalian ribosomes. It is well
known that aminoglycoside antibiotics can induce misreading
of mRNA, thus decreasing the fidelity of the translation pro-
cess (4, 28, 33). In the absence of antibiotics, the poly(U)-
induced leucine misincorporation was very small because
mRNA does not contain leucine codons (CUN and UUpu-
rine). However, the addition of paromomycin elicited a very
significant increase in errors when translation reactions were
carried out in parasite extracts. We determined the frequency
of mistranslation by calculating the ratio of leucine to phenyl-
alanine incorporation into polypeptides induced by poly(U).
We used cell-free systems containing purified ribosomes from
Crithidia, Leishmania, or rat liver and the same S150 superna-
tant fraction prepared from Leishmania mexicana. The reac-
tions were carried out in the absence or presence of various
paromomycin concentrations. Different aliquots from each
preparation were used to measure leucine and phenylalanine
incorporation, as detailed in Materials and Methods. Figure
4A shows the misreading frequency in reaction mixtures with
or without the addition of 20 M paromomycin. The presence
of the antibiotic markedly increased the misreading in mixtures
containing ribosomal particles from protozoa compared to re-
sults in those assays with mammalian ribosomes. This effect
was remarkably higher with ribosomes from Leishmania mexi-
cana. The misreading frequencies with Leishmania and rat
liver ribosomes were also measured at different paromomycin
levels (Fig. 4B). Mistranslation was substantially higher when
protozoan particles were used (15-fold at 20 M paromomycin
to 7-fold at 80 M antibiotic). The marked misreading de-
crease at higher paromomycin concentrations agrees with the
multistep model of aminoglycosides action on polypeptide syn-
thesis (9). Thus, when ribosomes are strongly blocked by high
levels of the drug, it could be expected that the residual protein
synthesis might produce short polypeptides with lower mis-
reading probability.
Interaction between aminoglycoside antibiotics and proto-
zoan or mammalian rRNA decoding site. The described results
related to the induction of translational misreading seem to
indicate a strong selective interaction between aminoglycoside
antibiotics and Leishmania cytoplasmic ribosomes. For a long
time, it has been known that these drugs bind specifically to a
region of the small subunit rRNA decoding A site (11, 12, 24).
This rRNA segment is involved in the codon-anticodon recog-
nition occurring during the translation mechanism. The struc-
ture of RNA-paromomycin complexes has been determined by
chemical footprinting techniques and more recently by nuclear
magnetic resonance spectroscopy and X-ray crystallography
(11, 21, 36). Based on previous results with Escherichia coli
ribosomes, we chose model oligomers for our studies on paro-
momycin affinities to rRNA from Leishmania mexicana (oli-
gomer L) and mammalian cells (oligomer M). The oligoribo-
nucleotides used correspond to the eukaryotic counterparts of
the antibiotic binding site in these organisms (14). We included
in our experiments a similar oligomer (N) with an unrelated
FIG. 3. Effect of paromomycin on polyphenylalanine synthesis in
cell-free systems. (A and B) S30 cell fractions were obtained from the
Crithidia fasciculata (F) or Leishmania mexicana (E) trypanosomatid
parasites (A) or rat liver (B). (C) Polypeptide synthesis in reaction
mixtures containing an S150 supernatant fraction from Leishmania
mexicana and purified ribosomes prepared from rat liver (Œ) or Leish-
mania (f) extracts in the presence of different antibiotic concentra-
tions. Samples were incubated and treated as described in Materials
and Methods. All values correspond to the average  SD of three
determinations.
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sequence around the antibiotic binding site as a negative con-
trol. The oligoribonucleotides containing biotin at their 5-
terminal end were immobilized on streptavidin-coated sensor
chips as described in Materials and Methods. An average coat-
ing of 1,500 RU of oligomers was achieved, and the surface
plasmon resonance analysis was performed with serial dilu-
tions of various antibiotics used as ligands. The sensorgrams
for interaction between the antibiotics and rRNA are depicted
in Fig. 5. Association and dissociation were achieved rapidly,
and the regeneration of the surface was conducted using
Na2SO4. A strong binding of paromomycin and neomycin B to
Leishmania rRNA can be seen (Fig. 5A and B). The corre-
sponding steady-state affinity analysis is shown in Fig. 5C
(paromomycin) and D (neomycin B). The apparent KD values
of these interactions determined by nonlinear regression were
(1.7  0.3)  103 and (6.2  0.7)  104 M, respectively.
Attempts to determine the association and dissociation rates
for paromomycin binding to Leishmania rRNA were unsuc-
cessful due to the extremely fast processes. However, neomycin
B showed lower rates for both, which could be determined as
an association rate (kon) of 267.9 M1 s1 and a dissociation
rate (koff) of (1.66  0.35)  101 s1. Conversely to the case
with aminoglycosides, the -lactam antibiotic ampicillin
showed no binding to Leishmania mexicana RNA (Fig. 5F) or
mammalian RNA (not shown). We also analyzed binding of
paromomycin to immobilized human rRNA and found that
none of the paromomycin concentrations showed specific bind-
ing (Fig. 5E). These results can explain the selective effects of
paromomycin on Leishmania ribosomes.
DISCUSSION
Increasing levels of Leishmania resistance to the antimonial
compounds used for many years as antiparasitic agents have
led to the search for new and less toxic drugs potentially useful
in leishmaniasis chemotherapy. Paromomycin, an aminoglyco-
side antibiotic originally used as an antibacterial agent, has
been shown to be effective against Leishmania infections when
used either alone or in combined formulations with other
drugs (7, 20).
In order to understand the selective activity shown by paro-
momycin against parasites at the molecular level, with almost
no effect on host cell metabolism and survival, we have inves-
tigated the process of protein synthesis in both cell systems and
how they are affected by aminoglycoside antibiotics. In vivo
translation experiments with Leishmania represent total pro-
tein synthesis carried out by cytoplasmic and mitochondrial
ribosomes. In contrast, in vitro assays were performed with
postmitochondrial extracts, and therefore, their results corre-
spond only to cytoplasmic ribosome polypeptide synthesis.
It is worth mentioning that even using Leishmania promas-
tigotes, which are less sensitive to paromomycin than amasti-
gotes (15), we detected a strong antibiotic inhibition on
polypeptide synthesis with systems containing parasite ribo-
somes, while only a small effect on mammalian cell ribosomal
particles was obtained under the same conditions (Fig. 3).
The marked differential inhibition by paromomycin of poly-
phenylalanine synthesis induced by synthetic mRNA in proto-
zoan extracts seems to be related to the stability of ribosomal
monomers. It has been shown that particle dissociation into
ribosomal subunits at low Mg2 concentration in Leishmania
was almost completely abolished in the presence of paromo-
mycin (17). Under these conditions, ribosomes released after
each round of mRNA translation might occur mainly as mono-
mers which are unable to again bind the poly(U) molecules
and therefore cannot reinitiate protein synthesis. Conversely,
ribosomes from mammalian cells are more stable than their
parasite counterparts, and the corresponding polypeptide syn-
thesis seems to be less affected by the antibiotic.
FIG. 4. Effect of paromomycin on translation misreading. (A) Reaction mixtures containing an S150 supernatant fraction from Leishmania
mexicana and purified ribosomal particles from trypanosomatid parasites (Crithidia fasciculata or Leishmania mexicana) or rat liver (mammalian
cells system) were assayed in the absence and presence of 20 M paromomycin. RL, Cf, and Lm, rat liver, Crithidia fasciculata, and Leishmania
mexicana ribosomes, respectively. (B) The reaction mixtures contained an S150 fraction from Leishmania mexicana and purified ribosomes from
Leishmania (E) or rat liver (F). Assays were carried out at different paromomycin concentrations. Misreading frequencies shown are the average
values  SD for three experiments.
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Misreading is a normal event in protein synthesis leading to
the incorporation of an erroneous amino acid in the growing
polypeptide chain due to a mismatch in the codon-anticodon
recognition step on the ribosome. Basal misreading in cell-free
systems occurs at a frequency of 1 to 5  103, but it can be
altered by ribosomal mutations, changes in salt concentrations
in the intracellular pool, or the presence of some antibiotics
(28). The normal misreading frequency may reach values as
FIG. 5. Surface plasmon resonance analysis (SPR) of the interaction of aminoglycoside antibiotics with L. mexicana rRNA. (A) SPR
sensorgram of the interactions between paromomycin (8 to 0.06 mM) and immobilized L. mexicana rRNA (1,450 RU) after correction of
nonspecific binding. (B) SPR sensorgram of the interaction of neomycin B (2 to 0.03 mM) and immobilized L. mexicana rRNA (1,560 RU) after
correction of nonspecific binding. (C and D) Nonlinear analysis for the determination of the apparent KD of the interaction between immobilized
L. mexicana rRNA and aminoglycoside antibiotics, paromomycin, and neomycin B, respectively. (E) SPR sensorgram of the interactions between
paromomycin (8 to 0.06 mM) and immobilized human rRNA (1,400 RU). (F) SPR sensorgram of the interactions between ampicillin (8 to 0.06
mM) and immobilized L. mexicana rRNA (1,510 RU). The sensorgrams are representative of at least three different experiments.
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high as 1 to 2% when working with eukaryotic systems in the
presence of a synthetic mRNA, such as poly(U). The most
likely misreading errors involve a single base-pair mismatch
between codon and anticodon, and this relationship is main-
tained in the presence of error-inducing antibiotics (8). A mis-
match of more than one base pair in the same codon has very
low probability. The standard assay to calculate the frequency
of mistranslation in a cell-free system involves the measure-
ment of the relative incorporation of leucine compared to that
of phenylalanine when poly(U) is used as mRNA. Codons for
phenylalanine are UUU and UUC, and those for leucine are
CUU, CUC, UUA, UUG, CUA, and CUG. Misreadings in-
duced by aminoglycoside antibiotics are usually errors at the
first or third position of the codon (28). These errors should
cause the incorporation of leucine instead of phenylalanine in
the reaction mixtures used in the present study. Figure 4A
shows that the misreading frequency induced by paromomycin
in the mammalian system was slightly higher than the basal
error level. Conversely, the erroneous incorporation of leucine
in the reaction mixture containing Leishmania ribosomes was
remarkably higher at different concentrations of the antibiotic
(Fig. 4A and B), with misreading frequencies reaching values
between 25 and 75%.
We have shown that paromomycin drastically alters the ac-
curacy of protein synthesis in Leishmania, markedly increasing
the misreading levels. Some defective proteins formed under
these conditions might cause deleterious effects on parasite
survival. Our results indicate that the antibiotic binds to the
parasite ribosomal decoding site, modifying the codon-antico-
don recognition process. In order to investigate the specificity
of the interaction between paromomycin and the A-site of
Leishmania rRNA, we carried out a surface plasmon reso-
nance analysis using different oligoribonucleotides as putative
targets (Fig. 5). The sensorgrams obtained show that while
paromomycin displays a rather high affinity for the polymer
corresponding to the decoding site of Leishmania rRNA (oligo-
mer L), the interactions with rRNA from mammalian cells
(oligomer M) or a negative control (N) were negligible (Fig. 5).
After sequence alignment of paromomycin binding sites on
Leishmania and prokaryotic ribosomes, Hobbie et al. (14) have
concluded that the substitution of a single base G for A in a
bulged region of bacterial small subunit rRNA helix 44 is able
to elicit a remarkable increase in paromomycin affinity for
bacterial particles.
It is interesting to point out that although neomycin B, a very
closely related paromomycin analog, showed a higher affinity
for the Leishmania rRNA decoding site (Fig. 5B), it could not
inhibit either in vivo protein synthesis or proliferation in cul-
tures of Leishmania mexicana promastigotes (Fig. 1 and 2).
This neomycin deficiency might be due to poor uptake of the
antibiotic by parasites (15) or to its chemical inactivation oc-
curring intracellularly (17). On the other hand, streptomycin,
another aminoglycoside antibiotic used in this work, also did
not affect either protein synthesis or parasite proliferation.
These results agree with those of previous reports concluding
that streptomycin binds rRNA in a region not involving the A
site (37). In addition, recent studies on crystallized ribosome-
antibiotic complexes have allowed new insights into the specific
recognition details at the antibiotic-binding pockets of ribo-
somal particles (2, 22, 25).
All the results described in the present work strongly suggest
that paromomycin can discriminate between ribosomes of
Leishmania and mammalian cells and that this marked differ-
ential effect may account for the effectiveness shown by the
antibiotic against leishmaniasis.
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